236 related articles for article (PubMed ID: 18391618)
1. Systemic therapy for hepatocellular carcinoma.
Thomas MB
Cancer J; 2008; 14(2):123-7. PubMed ID: 18391618
[TBL] [Abstract][Full Text] [Related]
2. Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?
Zhu AX
Oncologist; 2006; 11(7):790-800. PubMed ID: 16880238
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR
J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapies for hepatocellular carcinoma.
Skelton MR; O'Neil B
Clin Adv Hematol Oncol; 2008 Mar; 6(3):209-18. PubMed ID: 18391920
[TBL] [Abstract][Full Text] [Related]
5. Molecularly targeted therapy in hepatocellular carcinoma.
Huynh H
Biochem Pharmacol; 2010 Sep; 80(5):550-60. PubMed ID: 20371362
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy in hepatocellular carcinoma.
Okada S
Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1259-63. PubMed ID: 9730385
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy of hepatocellular cancer.
Wysocki PJ
Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
[TBL] [Abstract][Full Text] [Related]
8. Opportunities for targeted therapies in hepatocellular carcinoma.
Thomas MB; Abbruzzese JL
J Clin Oncol; 2005 Nov; 23(31):8093-108. PubMed ID: 16258107
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular carcinoma].
Kondo S; Ueno H; Morizane C; Okusaka T
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1219-23. PubMed ID: 20647702
[TBL] [Abstract][Full Text] [Related]
10. Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents.
Chaparro M; González Moreno L; Trapero-Marugán M; Medina J; Moreno-Otero R
Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1269-77. PubMed ID: 18808443
[TBL] [Abstract][Full Text] [Related]
11. Systemic treatment in hepatocellular carcinoma; 'A small step for man...'.
Witjes CD; Verhoef C; Verheul HM; Eskens FA
Neth J Med; 2009 Mar; 67(3):86-90. PubMed ID: 19307678
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma.
Zender L; Kubicka S
Onkologie; 2008 Oct; 31(10):550-5. PubMed ID: 18854656
[TBL] [Abstract][Full Text] [Related]
13. Systemic therapies in hepatocellular carcinoma.
Wörns MA; Weinmann A; Schuchmann M; Galle PR
Dig Dis; 2009; 27(2):175-88. PubMed ID: 19546557
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib for the treatment of unresectable hepatocellular carcinoma.
Kane RC; Farrell AT; Madabushi R; Booth B; Chattopadhyay S; Sridhara R; Justice R; Pazdur R
Oncologist; 2009 Jan; 14(1):95-100. PubMed ID: 19144678
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase inhibitors to treat liver cancer.
Huynh H
Expert Opin Emerg Drugs; 2010 Mar; 15(1):13-26. PubMed ID: 20128706
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M
Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684
[TBL] [Abstract][Full Text] [Related]
17. Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies.
Lord R; Suddle A; Ross PJ
Int J Clin Pract; 2011 Feb; 65(2):182-8. PubMed ID: 21235699
[TBL] [Abstract][Full Text] [Related]
18. Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now?
Finn RS
Clin Cancer Res; 2010 Jan; 16(2):390-7. PubMed ID: 20068087
[TBL] [Abstract][Full Text] [Related]
19. Improved chemotherapy for hepatocellular carcinoma.
Cao H; Phan H; Yang LX
Anticancer Res; 2012 Apr; 32(4):1379-86. PubMed ID: 22493374
[TBL] [Abstract][Full Text] [Related]
20. Growth factors as therapeutic targets in HCC.
Furuse J
Crit Rev Oncol Hematol; 2008 Jul; 67(1):8-15. PubMed ID: 18434184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
